Military Health Initiative: New Testosterone Screening Protocol for Service Members

US military to start screening for testosterone – United States Defence Secretary Pete Hegseth has unveiled a comprehensive new health initiative aimed at optimizing military readiness through hormonal assessment. The programme mandates that all service members aged thirty and above will participate in testosterone deficiency screening as a routine component of their annual health evaluations. This announcement was delivered through a video message shared on the social media platform X, which Hegseth titled “High-T Department” to capture public attention.

According to the Defence Secretary, the primary objective is to guarantee that personnel maintain optimal hormonal levels necessary for peak physical and mental performance. Hegseth emphasized that this initiative represents a commitment to providing exceptional medical support to those who serve. The screening process will be integrated into the Periodic Health Assessment, ensuring systematic evaluation across the force.

Implementation Details and Scope

Chief Pentagon Spokesman Sean Parnell provided additional clarification regarding the programme’s parameters. He confirmed that both Active Duty and Reserve Component personnel meeting the age requirement will undergo mandatory testing. However, the initiative also offers flexibility for younger service members. Personnel below the age threshold may voluntarily request screening if they wish to monitor their hormonal health proactively.

“We owe our warriors the absolute best medical care in the world, and this programme delivers on that obligation,” Hegseth explained in Wednesday’s video.

The Defence Secretary further elaborated on the long-term benefits of this approach. He noted that maintaining hormonal balance contributes to sustained strength and resilience throughout a service member’s career and beyond. The goal extends beyond immediate deployment readiness to encompass lifelong health outcomes for veterans transitioning to civilian life.

Clarifying the Purpose: Therapy vs. Enhancement

A critical distinction has been drawn between medical treatment and performance enhancement. The military maintains strict prohibitions against non-medical testosterone use, particularly artificial muscle building without proper medical supervision. Hegseth explicitly stated that the new programme focuses on therapeutic intervention rather than cosmetic or performance boosting purposes.

“The protocol will enable the Department to establish a comprehensive baseline and offer targeted testosterone therapy, ensuring that it sustains a healthy, capable, and decisively dominant fighting force,” Parnell added in his written statement.

When questioned about potential inclusion of female service members and estrogen-based therapy for those entering perimenopause, the Pentagon declined to provide additional commentary beyond the existing statements from Hegseth and Parnell.

Political Reactions and Expert Perspectives

The announcement has generated varied responses from political figures. Democratic Senator Tammy Duckworth of Illinois, an Iraq war veteran serving on the armed services committee, advocated for inclusive hormone testing that encompasses both male and female personnel. Conversely, Congresswoman Chrissy Houlahan, a Pennsylvania Democrat and Air Force veteran, characterized the initiative as Hegseth’s “latest culture-war obsession” on social media.

Medical experts have provided valuable context for understanding the scientific basis of the screening programme. Dr. Mohit Khera, who chaired a US Food and Drug Administration expert panel on military testosterone utilization, offered comprehensive insights into the physiological rationale behind the initiative.

“The key here is that many young men have low testosterone levels, which puts them at a disadvantage in terms of muscle mass, energy, and that could be an issue if you are in combat,” Khera, a professor of urology at Baylor College of Medicine, said.

Understanding Testosterone and Its Impact

Testosterone production follows a natural trajectory throughout human development. Levels typically increase significantly during puberty, contributing to muscle development, body hair growth, and sperm production. However, a gradual decline begins sometime between ages thirty and forty, affecting a substantial portion of the male population.

Research estimates suggest that low testosterone impacts between ten and forty percent of older men worldwide, representing approximately thirteen million American men. Common symptoms associated with deficiency include diminished mood, reduced libido, and decreased muscle mass. Diagnosis requires blood testing, with treatment options available for those who qualify.

Dr. Khera emphasized the importance of careful patient selection. While hormone replacement therapy offers benefits including increased muscle mass, reduced fat deposition, and lower depression risk, it is not universally appropriate. The specialist warned that testosterone supplementation can cause infertility in men of reproductive age and may carry theoretical cardiovascular risks.

This military initiative aligns with broader federal efforts to facilitate testosterone access. US Health Secretary Robert F. Kennedy Jr. and other administration officials have worked to eliminate regulatory barriers that previously restricted medical professionals from prescribing the hormone. The FDA recently requested modifications to safety and effectiveness language in testosterone-related regulations, further supporting this trend toward expanded medical access.